Back to News
Market Impact: 0.15
Biotech Stocks At 52-Week Highs - CDNA +13%, GRAL +15%, TWST +16%, ADPT, RVTY
Source: Nasdaq
Healthcare & BiotechMarket Technicals & Flows
Biotech stocks reached 52-week highs on September 24, 2026, supported by regulatory milestones and clinical-trial results. The report does not identify specific companies, trial data, or regulatory decisions, limiting its broader market significance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Bond market alarms are ringing on Wall Street. Here's what's ahead
- Warsh's regime change at the Fed pushes ahead – and meets resistance
- Wall Street Week | China’s Trade Reckoning, Syracuse’s Second Chance, Humanoids in Healthcare
- Oil Prices Decline on Hopes of a Hormuz Deal
- Chartstopper: September 25, 2026
- Bond Selloff Fades, US-Iran Said to be Exploring Phased Deal, Trump-Xi Summit